Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 14:2021:6667047.
doi: 10.1155/2021/6667047. eCollection 2021.

Fluid and Electrolyte Disturbances in COVID-19 and Their Complications

Affiliations
Review

Fluid and Electrolyte Disturbances in COVID-19 and Their Complications

Mohammad Pourfridoni et al. Biomed Res Int. .

Abstract

The novel coronavirus disease 2019 (COVID-19) is the cause of an acute respiratory illness which has spread around the world. The virus infects the host by binding to the angiotensin-converting enzyme 2 (ACE2) receptors. Due to the presence of ACE2 receptors in the kidneys and gastrointestinal (GI) tract, kidneys and GI tract damage arising from the virus can be seen in patients and can cause acute conditions such as acute kidney injury (AKI) and digestive problems for the patient. One of the complications of kidneys and GI involvement in COVID-19 is fluid and electrolyte disturbances. The most common ones of these disorders are hyponatremia, hypernatremia, hypokalemia, hypocalcemia, hypochloremia, hypervolemia, and hypovolemia, which if left untreated, cause many problems for patients and even increase mortality. Fluid and electrolyte disturbances are more common in hospitalized and intensive care patients. Children are also at greater risk for fluid and electrolyte disturbances complications. Therefore, clinicians should pay special attention to the fluid and electrolyte status of patients. Changes in fluid and electrolyte levels can be a good indicator of disease progression.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this paper.

References

    1. Chan J. F.-W., Yuan S., Kok K.-H., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395(10223):514–523. doi: 10.1016/S0140-6736(20)30154-9. - DOI - PMC - PubMed
    1. WHO Coronavirus (COVID-19) dashboard | WHO coronavirus disease (COVID-19) dashboard. March 2021, https://covid19.who.int/
    1. Fehr A. R., Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods in Molecular Biology. 2015;1282:1–23. doi: 10.1007/978-1-4939-2438-7_1. - DOI - PMC - PubMed
    1. Zhu N., Zhang D., Wang W., et al. A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine. 2020;382(8):727–733. - PMC - PubMed
    1. Su S., Wong G., Shi W., et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology. 2016;24(6):490–502. doi: 10.1016/j.tim.2016.03.003. - DOI - PMC - PubMed

LinkOut - more resources